These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24010212)

  • 1. [Testosterone deficiency: an independent risk factor of cardiovascular disease].
    Qing XR; Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2013 Aug; 19(8):742-7. PubMed ID: 24010212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens, cardiovascular disease and osteoporosis.
    Isidori AM; Giannetta E; Pozza C; Bonifacio V; Isidori A
    J Endocrinol Invest; 2005; 28(10 Suppl):73-9. PubMed ID: 16550728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone deficiency: a risk factor for cardiovascular disease?
    Jones TH
    Trends Endocrinol Metab; 2010 Aug; 21(8):496-503. PubMed ID: 20381374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone deficiency as a risk factor for cardiovascular disease.
    Ullah MI; Washington T; Kazi M; Tamanna S; Koch CA
    Horm Metab Res; 2011 Mar; 43(3):153-64. PubMed ID: 21283952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testosterone deficiency in elderly men].
    Rabijewski M; Zgliczyński W
    Pol Merkur Lekarski; 2009 Dec; 27(162):517-23. PubMed ID: 20120721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency.
    Yassin AA; Akhras F; El-Sakka AI; Saad F
    Andrologia; 2011 Feb; 43(1):1-8. PubMed ID: 21219375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone: a vascular hormone in health and disease.
    Kelly DM; Jones TH
    J Endocrinol; 2013 Jun; 217(3):R47-71. PubMed ID: 23549841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA; Breda V; Lhullier F; Spritzer PM
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone supplementation: why and for whom?
    Gooren L
    Aging Male; 2003 Sep; 6(3):184-99. PubMed ID: 14628499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.
    Carrero JJ; Qureshi AR; Nakashima A; Arver S; Parini P; Lindholm B; Bárány P; Heimbürger O; Stenvinkel P
    Nephrol Dial Transplant; 2011 Jan; 26(1):184-90. PubMed ID: 20624775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and the ageing male.
    Swerdloff RS; Wang C
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):349-62. PubMed ID: 15261842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.